555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [xổ số bữa nay]
Check out professional insights posted by Uday Kompella, Professor of Pharmaceutics, Ophthalmology, and Bioengineering at University of Colorado
Lab: V20-4460D (N)/4470. Office: V20-4129. Aurora, CO 80045. MPharm (Pharm. Engg.) – Jadavpur University, Kolkata, India.
View Uday Kompella’s profile on LinkedIn, a professional community of 1 billion members.
Research in the Kompella lab is currently focused on nanotechnology as it pertains to drug and gene delivery via ocular, nasal, and pulmonary routes of administration.
Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat …
Uday Kompella PhD, FARVO, FAAPS Colorado Center for Nanomedicine and Nanosafety Co-Director and Co-founder Professor of Pharmaceutical Sciences, Ophthalmology, and Bioengineering
Our previous studies indicated that while 20 nm particles are rapidly cleared from the periocular space of the rat following posterior subconjunctival injection, 200 nm particles persisted for at...
Uday Kompella, PhD Professor, University of Colorado - Denver Department University of Colorado - Denver
Editor, Expert Reviews, Pharmaceutical Research, A Springer journal (responsibilities include a) managing the article invitations, peer reviews, and decision making on acceptability of articles; and b) developing and implementing strategic plans to enhance the journals impact by identifying key areas of future focus and by recruiting high ...
Wang J, Li B, Kompella UB, Yang H. Dendrimer and dendrimer gel-derived drug delivery systems: Breaking bottlenecks of topical administration of glaucoma medications.
Bài viết được đề xuất: